![Fredrik Ollila](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Fredrik Ollila
Fondatore presso BonAlive Biomaterials Oy
Posizioni attive di Fredrik Ollila
Società | Posizione | Inizio | Fine |
---|---|---|---|
BonAlive Biomaterials Oy
![]() BonAlive Biomaterials Oy Medical SpecialtiesHealth Technology BonAlive Biomaterials Oy is a holding company that provides solutions to heal patients with bone defects. It develops synthetic biomaterial solutions for the treatment of chronically infected bone. Their products include BonAlive granules and BonAlive putty, which are osteostimulative; BonAlive granules, which inhibits bacterial growth and act as tool for bone cavity filling in the treatment of chronic osteomyelitis; and BonAlive plates, which have been designed for repair of orbital floor trauma. The company was founded by Fredrik Viktor Ollila on November 13, 2009 and is headquartered in Turku, Finland. | Direttore/Membro del Consiglio | 13/11/2009 | - |
Fondatore | 13/11/2009 | - | |
Amministratore Delegato | 13/11/2009 | 02/10/2023 |
Storia della carriera di Fredrik Ollila
Precedenti posizioni note di Fredrik Ollila
Società | Posizione | Inizio | Fine |
---|---|---|---|
Vivoxid Oy
![]() Vivoxid Oy BiotechnologyHealth Technology Vivoxid Oy develops, manufactures and markets biomaterial products and production services within the medical device sector. The company was founded on January 14, 2002 and is headquartered in Helsinki, Finland. | Vendite & Marketing | 01/01/2006 | 06/01/2014 |
Novartis Pharma AG
![]() Novartis Pharma AG Pharmaceuticals: MajorHealth Technology Novartis Pharma AG engages in the research in as well as the production and distribution of pharmaceutical, chemical, medical, and biotechnological products. It also provides related services. The company was founded on October 25, 1989 and is headquartered in Basel, Switzerland. | Corporate Officer/Principal | - | - |
NOVARTIS AG | Corporate Officer/Principal | 01/01/2002 | - |
Formazione di Fredrik Ollila
Åbo Akademi University | Doctorate Degree |
University of Turku | Undergraduate Degree |
Statistiche
Distribuzione geografica
Finlandia | 5 |
Svizzera | 3 |
Posizioni
Corporate Officer/Principal | 2 |
Sales & Marketing | 1 |
Doctorate Degree | 1 |
Settori
Health Technology | 5 |
Consumer Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 1 |
---|---|
NOVARTIS AG | Health Technology |
Aziende private | 3 |
---|---|
Vivoxid Oy
![]() Vivoxid Oy BiotechnologyHealth Technology Vivoxid Oy develops, manufactures and markets biomaterial products and production services within the medical device sector. The company was founded on January 14, 2002 and is headquartered in Helsinki, Finland. | Health Technology |
Novartis Pharma AG
![]() Novartis Pharma AG Pharmaceuticals: MajorHealth Technology Novartis Pharma AG engages in the research in as well as the production and distribution of pharmaceutical, chemical, medical, and biotechnological products. It also provides related services. The company was founded on October 25, 1989 and is headquartered in Basel, Switzerland. | Health Technology |
BonAlive Biomaterials Oy
![]() BonAlive Biomaterials Oy Medical SpecialtiesHealth Technology BonAlive Biomaterials Oy is a holding company that provides solutions to heal patients with bone defects. It develops synthetic biomaterial solutions for the treatment of chronically infected bone. Their products include BonAlive granules and BonAlive putty, which are osteostimulative; BonAlive granules, which inhibits bacterial growth and act as tool for bone cavity filling in the treatment of chronic osteomyelitis; and BonAlive plates, which have been designed for repair of orbital floor trauma. The company was founded by Fredrik Viktor Ollila on November 13, 2009 and is headquartered in Turku, Finland. | Health Technology |
- Borsa valori
- Insiders
- Fredrik Ollila
- Esperienza